Laboratory:Akiruno
- TOP
- biochemical test
- lipids and related materials
Laboratory:Akiruno
○lipids and related materials
TEST NAME |
SPECIMEN REQUIREMENT (mL) |
CONTAINER | CAP COLOR | STORE TEMPERATURE (STABILITY) |
TURNAROUND TIME (DAY) |
METHODOLOGY | REFERENCE RANGE (UNIT) |
---|---|---|---|---|---|---|---|
Triglycerides (TG)
|
Serum
0.5 |
S09 ↓ A00 |
(1 month) |
2-4 |
Enzymatic method(GK-GPO free glycerol blank) Enzymatic method |
50-149(mg/dL) | |
Phospholipid
|
Serum
0.5 |
S09 ↓ A00 |
(21 days) |
2-4 |
Enzymatic method Enzymatic method |
160-260(mg/dL) | |
Free (or non-esterified) fatty acid(NEFA)
|
Serum
0.3 |
S09 ↓ A00 |
(28 days) |
2-4 |
Enzymatic method Enzymatic method |
140-850(μEq/L) | |
Total cholesterol (T-Cho)
|
Serum
0.5 |
S09 ↓ A00 |
(1 month) |
2-4 | Cholesterol oxidase (COD-POD) method | 150-219(mg/dL) | |
Esterified cholesterol (Echo)
|
Serum
0.5 |
S09 ↓ A00 |
(28 days) |
2-4 |
Cholesterol oxidase(COD-POD) method, Enzymatic method Enzymatic method |
90-200(mg/dL) | |
Free cholesterol (F-Cho)
|
Serum
0.5 |
S09 ↓ A00 |
(28 days) |
2-4 |
Enzymatic method Enzymatic method |
30-60(mg/dL) | |
Cholesterol ester rate
|
Serum
0.5 |
S09 ↓ A00 |
(28 days) |
2-4 |
Cholesterol oxidase(COD-POD) method, Enzymatic method Enzymatic method |
73-77(%) | |
HDL-cholesterol
|
Serum
0.5 |
S09 ↓ A00 |
(1 month) |
2-4 | direct method |
M 40-86 F 40-96 (mg/dL) |
|
HDL2, 3-cholesterol
|
Serum
1.0 |
S09 ↓ A00 |
(20 days) |
2-6 |
ultracentrifugation method Ultracentrifugation method |
HDL2 Cholesterol M 16.0-61.0 F 23.0-73.0 HDL3 Cholesterol M 13.0-25.0 F 13.0-24.0 (mg/dL) |
|
LDL-cholesterol
|
Serum
0.5 |
S09 ↓ A00 |
(1 month) |
2-4 | direct method | 70-139(mg/dL) | |
Remnant-like particles-cholesterol (RLP-C)
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
Enzymatic method Enzymatic method |
7.5 or less (mg/dL) | |
sd LDL-cholesterol
|
Serum
0.5 |
S09 ↓ A00 |
(5 days) |
2-4 | direct method | Less than 35.0 (mg/dL) | |
Oxidized LDL (MDA-LDL)
|
Serum
0.3 |
S09 ↓ A00 |
(21 days) |
3-14 |
ELISA ELISA (Enzyme-Linked immunosorbent assay) |
Male Under 45 years old 46-82 Over 45 years old 61-105 Female Under 55 years old 46-82 Over 55 years old 61-105 (U/L) |
|
sd LDL-C (physical examination)
|
Serum
0.5 |
S09 ↓ A00 |
(5 days) |
2-4 | direct method | (mg/dL) | |
Fatty acid fractionation (24)
|
Plasma
0.5 |
PH5 ↓ A00 |
(45 days) |
10-14 |
Gas-Chromatograph method Chromatography |
See below | |
Fatty acid fractionation (24)
|
Serum
0.5 |
S09 ↓ A00 |
(45 days) |
10-14 |
Gas-Chromatograph method Chromatography |
See below | |
Fatty acid fractionation (4)
|
Plasma
0.5 |
PH5 ↓ A00 |
(45 days) |
4-6 |
Gas-Chromatograph method Chromatography |
Dihomo-γ-linolenic acid 22.6-72.5 Arachidonic acid 135.7-335.3 Eicosapentaenoic acid 10.2-142.3 Docosahexaenoic acid 54.8-240.3 (μg/mL) EPA/AA ratio 0.05-0.61 DHA/AA ratio 0.27-1.07 (EPA +DHA)/ AA ratio 0.32-1.66 | |
Fatty acid fractionation (4)
|
Serum
0.5 |
S09 ↓ A00 |
(45 days) |
4-6 |
Gas-Chromatograph method Chromatography |
Dihomo-γ-linolenic acid 22.6-72.5 Arachidonic acid 135.7-335.3 Eicosapentaenoic acid 10.2-142.3 Docosahexaenoic acid 54.8-240.3 (μg/mL) EPA/AA ratio 0.05-0.61 DHA/AA ratio 0.27-1.07 (EPA +DHA)/ AA ratio 0.32-1.66 | |
Very long chain fatty acid
|
Plasma
2.0 |
PH5 ↓ A00 |
(1 month) |
6-19 |
Gas chromatography method (GC-MS) Chromatography |
C24:0/C22:0 0.628-0.977 C25:0/C22:0 0.012-0.023 C26:0/C22:0 0.003-0.006 |
|
Total bile acids
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
Enzymatic method Enzymatic method |
10.0 or less (μmol/L) | |
β-lipoprotein
|
Serum
0.5 |
S09 ↓ A00 |
(21 days) |
2-4 |
immunoturbidimetric method TIA (Turbidimetric immnoassay) |
220-650(mg/dL) | |
Lipoprotein fractionation
|
Serum
0.2 |
S09 ↓ A00 |
(7 days) |
2-4 |
Agarose gel electrophoresis Electrophoresis method |
α M26.9-50.5 F32.6-52.5 PREβ M7.9-23.8 F6.6-20.8 β M35.3-55.5 F33.6-52.0 (%) |
|
Cholesterol fractionation
|
Serum
0.2 |
S09 ↓ A00 |
(7 days) |
2-4 |
Agarose gel electrophoresis Electrophoresis method |
HDL cholesterol 23-48 LDL cholesterol 47-69 VLDL cholesterol 2-15 (%) |
|
Lipoprotein (a)
|
Serum
0.5 |
S09 ↓ A00 |
(1 month) |
2-4 |
LA (latex agglutination turbidimetry) LA (Latex agglutination immunoassay) |
40 or less (Reference value)(mg/dL) | |
Lipoprotein lipase (LPL)
|
Plasma 0.3 |
PH5 ↓ A00 |
(1 month) |
2-8 |
ELISA ELISA (Enzyme-Linked immunosorbent assay) |
164-284(ng/mL) | |
Apolipoprotein A-I
|
Serum
0.3 |
S09 ↓ A00 |
(1 month) |
2-4 |
immunoturbidimetric method TIA (Turbidimetric immnoassay) |
M 119-155 F 126-165 (mg/dL) |
|
Apolipoprotein A-II
|
Serum
0.3 |
S09 ↓ A00 |
(1 month) |
2-4 |
immunoturbidimetric method TIA (Turbidimetric immnoassay) |
M 25.9-35.7 F 24.6-33.3 (mg/dL) |
|
Apolipoprotein B
|
Serum
0.3 |
S09 ↓ A00 |
(1 month) |
2-4 |
immunoturbidimetric method TIA (Turbidimetric immnoassay) |
M 73-109 F 66-101 (mg/dL) |
|
Apolipoprotein C-II
|
Serum
0.3 |
S09 ↓ A00 |
(1 month) |
2-4 |
immunoturbidimetric method TIA (Turbidimetric immnoassay) |
M 1.8-4.6 F 1.5-3.8 (mg/dL) |
|
Apolipoprotein C-III
|
Serum
0.3 |
S09 ↓ A00 |
(1 month) |
2-4 |
immunoturbidimetric method TIA (Turbidimetric immnoassay) |
M 5.8-10.0 F 5.4-9.0 (mg/dL) |
|
Apolipoprotein E
|
Serum
0.3 |
S09 ↓ A00 |
(1 month) |
2-4 |
immunoturbidimetric method TIA (Turbidimetric immnoassay) |
M 2.7-4.3 F 2.8-4.6 (mg/dL) |
|
Pulmonary surfactant protein A (SP-A)
|
Serum
0.3 |
S09 ↓ A00 |
|
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
Less than 43.8 (ng/mL) | |
Pulmonary surfactant protein D (SP-D)
|
Serum
0.5 |
S09 ↓ A00 |
|
2-4 |
CLEIA CLEIA (Chemiluminescent enzyme immunoassay) |
Less than 110 (ng/mL) | |
|
Serum
1.0 |
S09 ↓ A00 |
|
2-4 |
ultracentrifugation method Ultracentrifugal method |
See below | |
|
Serum
1.0 |
S09 ↓ A00 |
(20 days) |
2-4 |
ultracentrifugation method Ultracentrifugal method |
See below | |
|
Serum
0.5 |
S09 ↓ A00 |
(1 month) |
10-14 |
Gas-Chromatograph method Chromatography |
See below | |
|
Serum
0.2 |
S09 ↓ A00 |
(7 days) |
4-20 |
Immunoblot method using isoelectric focusing method Electrophoresis method |
||
|
Serum
0.3 |
S09 ↓ A00 |
(1 month) |
2-4 |
Enzymatic method Enzyme method |
140-850(μEq/L) | |
|
Plasma
0.5 |
PH5 ↓ A00 |
(35 days) |
4-6 |
Gas-Chromatograph method Chromatography |
Dihomo-γ-linolenic acid 22.6-72.5 Arachidonic acid 135.7-335.3 Eicosapentaenoic acid 10.2-142.3 Docosahexaenoic acid 54.8-240.3 (μg/mL) EPA/AA ratio 0.05-0.61 | |
|
Serum
1.5 |
S09 ↓ A00 |
|
Dipalmitoyl lecithin substrate method | |||
|
Plasma
0.5 |
PH5 ↓ A00 |
(1 month) |
10-14 |
Gas-Chromatograph method Chromatography |
See below | |
|
Serum
0.5 |
S09 ↓ A00 |
(35 days) |
4-6 |
Gas-Chromatograph method Chromatography |
Dihomo-γ-linolenic acid 22.6-72.5 Arachidonic acid 135.7-335.3 Eicosapentaenoic acid 10.2-142.3 Docosahexaenoic acid 54.8-240.3 (μg/mL) EPA/AA ratio 0.05-0.61 | |
|
Serum
0.5 |
S09 ↓ A00 |
(7 days) |
3-7 |
Polyacrylamide gel disk electrophoresis method Electrophoresis |
HDL M22-47 F27-50 LDL M46-68 F44-66 VLDL M3-19 F2-12 (%) |
|
|
Serum
0.2 |
S09 ↓ A00 |
|
2-8 |
RIA PEG method RIA (Radio immunoassay) |
50 or less (μg/dL) |